logo
Supertech EV IPO Day 1: GMP, subscription status, price band, other details of BSE SME IPO

Supertech EV IPO Day 1: GMP, subscription status, price band, other details of BSE SME IPO

Mint25-06-2025
Supertech EV IPO: The initial public offering (IPO) of electric vehicles (EVs) manufacturer Supertech EV Limited opened for subscription on Wednesday, June 25. The SME IPO is entirely a fresh issue to raise nearly ₹ ₹ 30 crore. Supertech EV IPO is witnessing decent subscription from retail and non-institutional buyers.
By 12:25 PM of the first day of subscription, the issue had been subscribed 0.51 times, with the retail portion booked 0.69 times and the segment reserved for non-institutional investors (NIIs) subscribed 0.39 times. The segment reserved for qualified institutional buyers had not seen any subscription thill then.
1. Supertech EV IPO GMP: According to market sources, the latest grey market premium (GMP) of Supertech EV shares was ₹ 15. The latest GMP indicates the stock could be listed at a 16% premium.
2. Supertech EV IPO date: The SME IPO opened for subscription on Wednesday, June 25, and will conclude on Friday, June 27.
3. Supertech EV IPO price: The price band of the public issue has been fixed at ₹ 87 to ₹ 92 per equity share.
4. Supertech EV IPO size: The company intends to raise nearly ₹ 30 crore from the issue, which it will use to meet working capital requirements, repay certain borrowings and for general corporate purposes.
5. Supertech EV IPO lot size: Bidders can apply in lots, and one lot of the SME IPO comprises 1,200 company shares.
6. Supertech EV IPO reservation: Nearly 43 per cent of the net issue is reserved for retail investors, and an equal portion is reserved for NIIs. QIBs have been allotted 4.5 per cent of the net issue, and 4.8 per cent is reserved for market makers.
7. Supertech EV IPO allotment date: The company is expected to finalise the share allotment on Monday, June 30. Successful bidders can expect shares of the company in their demat accounts on Tuesday, July 1, and bidders who fail to get the allocation may get a refund on the same day.
8. Supertech EV IPO book-running lead manager and registrar: Corporate Makers Capital Ltd is the book-running lead manager, while Skyline Financial Services Private Ltd is the registrar for the issue.
9. Supertech EV IPO listing: As per SEBI's T+3 rule of IPO listing, the SME IPO is proposed for listing on the BSE SME on Wednesday, Jul 2.
10. Supertech EV business overview: The company manufactures 12 EV models, including 8 variants of EVS, two-wheelers, and four variants of e-rickshaw electric vehicles, with facilities located in Haryana. It has a distributor base of 445 across India and a presence in 19 states.
Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share
Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share

Economic Times

time2 days ago

  • Economic Times

Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share

Patel Chem Specialities' ₹58.8 crore IPO opens on July 25 and closes on July 29. Proceeds will fund a new plant, corporate needs, and expansion. Listing is set for August 1 on BSE SME. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads IPO proceeds use About Patel Chem Specialities Patel Chem Specialities will open its Initial Public Offering (IPO) on Friday, July 25. The issue comprises a fresh offer of 70,00,000 equity shares with a face value of ₹10 each. The total issue size is ₹58.80 crore at the upper price band, with the price band set at ₹82 to ₹84 per share. The market lot is 1,600 equity anchor portion will open and close on July 24. The issue will close on July 29. The expected allotment date and credit to demat accounts is on or before July 31. The listing date is August 1 and will be listed on BSE Read | The Wealth Company receives Sebi approval to commence mutual fund business The share allocation for Qualified Institutional Buyers (QIB, including Anchor) is 33,16,800 shares, for Non-Institutional Investors (NII) is 9,98,400 shares, for Retail Individual Investors is 23,31,200 shares and for market maker is 3,53,600 lead managers are Cumulative Capital Private Limited and Unistone Capital Private Limited. The registrar to the issue is MUFG Intime India Private Limited (formerly Link Intime India Private Limited).The utilization of net proceeds will be for funding capital expenditure requirement of our company, to set up plant at Indrad, Mahesana for manufacturing Croscarmellose Sodium, Sodium Starch Glycolate – Corn Starch Base & Potato Starch Base and Calcium Carboxymethylcellulose (CMC), for general corporate purposes, and for issue-related expenses."The IPO proceeds will fuel our strategic expansion and strengthen our presence in both domestic and international markets. With a growing portfolio of pharmaceutical excipients and exports to over 15 countries, we are committed to timely and customized delivery through our advanced facilities in Vatva and Talod. The upcoming facility at Indrad, Mehsana will help us meet rising demand for key products like CCS, SSG, and Calcium CMC, and support our focus on innovation and customer-driven solutions," said Bhupesh Patel, Managing Director of Patel Chem Specialities."We are proud to partner with Patel Chem Specialities Limited for their IPO journey. The company's strong foundation in pharmaceutical excipients, backed by a seasoned leadership team and robust export footprint, positions it well for sustainable growth in a global market that's increasingly leaning on reliable, high-quality ingredients. This offering marks an important milestone not just for the company, but for investors seeking value in a rapidly evolving pharmaceutical ecosystem. With the upcoming facility in Indrad, their scale and innovation potential are set to expand meaningfully," said Swapnilsagar Vithalani, Co-founder and Director, Cumulative Capital Read | NFO Insight: Capitalmind Mutual Fund's flexi cap fund opens for subscription. Will it help to manage current market volatility? Established in 2008, Patel Chem Specialities Limited is a leading manufacturer of cellulose- and starch-based pharmaceutical excipients and is known for its commitment to global quality standards, according to a press company's products are integral to drug formulation processes and comply with global quality benchmarks. With a dedicated in-house R&D facility and an experienced technical team, the company offers customized, cost-effective, and innovative specialty chemical solutions across diverse of FY25, the company has an installed production capacity of 7,200 MT per year, with a capacity utilization rate of 89%.In FY25, the company reported a strong performance with Operating Revenue of Rs 105.09 crore, EBITDA of Rs 15.27 crore with Net Profit of Rs 10.57 crore.

Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share
Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share

Time of India

time2 days ago

  • Time of India

Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity share

Patel Chem Specialities will open its Initial Public Offering (IPO) on Friday, July 25. The issue comprises a fresh offer of 70,00,000 equity shares with a face value of ₹10 each. The total issue size is ₹58.80 crore at the upper price band, with the price band set at ₹82 to ₹84 per share. The market lot is 1,600 equity shares. The anchor portion will open and close on July 24. The issue will close on July 29. The expected allotment date and credit to demat accounts is on or before July 31. The listing date is August 1 and will be listed on BSE SME. Explore courses from Top Institutes in Select a Course Category Digital Marketing Data Analytics Artificial Intelligence Data Science Cybersecurity MBA Leadership Design Thinking CXO MCA Management Public Policy Technology Degree healthcare Project Management Product Management Healthcare others Others Data Science Finance PGDM Skills you'll gain: Digital Marketing Strategy Search Engine Optimization (SEO) & Content Marketing Social Media Marketing & Advertising Data Analytics & Measurement Duration: 24 Weeks Indian School of Business Professional Certificate Programme in Digital Marketing Starts on Jun 26, 2024 Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Morocco: Unsold Sofas Prices May Surprise You (Prices May Surprise You) Sofas | Search Ads Search Now Also Read | The Wealth Company receives Sebi approval to commence mutual fund business The share allocation for Qualified Institutional Buyers (QIB, including Anchor) is 33,16,800 shares, for Non-Institutional Investors (NII) is 9,98,400 shares, for Retail Individual Investors is 23,31,200 shares and for market maker is 3,53,600 shares. The lead managers are Cumulative Capital Private Limited and Unistone Capital Private Limited. The registrar to the issue is MUFG Intime India Private Limited (formerly Link Intime India Private Limited). Live Events IPO proceeds use The utilization of net proceeds will be for funding capital expenditure requirement of our company, to set up plant at Indrad, Mahesana for manufacturing Croscarmellose Sodium, Sodium Starch Glycolate – Corn Starch Base & Potato Starch Base and Calcium Carboxymethylcellulose (CMC), for general corporate purposes, and for issue-related expenses. "The IPO proceeds will fuel our strategic expansion and strengthen our presence in both domestic and international markets. With a growing portfolio of pharmaceutical excipients and exports to over 15 countries, we are committed to timely and customized delivery through our advanced facilities in Vatva and Talod. The upcoming facility at Indrad, Mehsana will help us meet rising demand for key products like CCS, SSG, and Calcium CMC, and support our focus on innovation and customer-driven solutions," said Bhupesh Patel, Managing Director of Patel Chem Specialities. "We are proud to partner with Patel Chem Specialities Limited for their IPO journey. The company's strong foundation in pharmaceutical excipients, backed by a seasoned leadership team and robust export footprint, positions it well for sustainable growth in a global market that's increasingly leaning on reliable, high-quality ingredients. This offering marks an important milestone not just for the company, but for investors seeking value in a rapidly evolving pharmaceutical ecosystem. With the upcoming facility in Indrad, their scale and innovation potential are set to expand meaningfully," said Swapnilsagar Vithalani, Co-founder and Director, Cumulative Capital Private. Also Read | NFO Insight: Capitalmind Mutual Fund's flexi cap fund opens for subscription. Will it help to manage current market volatility? About Patel Chem Specialities Established in 2008, Patel Chem Specialities Limited is a leading manufacturer of cellulose- and starch-based pharmaceutical excipients and is known for its commitment to global quality standards, according to a press release. The company's products are integral to drug formulation processes and comply with global quality benchmarks. With a dedicated in-house R&D facility and an experienced technical team, the company offers customized, cost-effective, and innovative specialty chemical solutions across diverse applications. As of FY25, the company has an installed production capacity of 7,200 MT per year, with a capacity utilization rate of 89%. In FY25, the company reported a strong performance with Operating Revenue of Rs 105.09 crore, EBITDA of Rs 15.27 crore with Net Profit of Rs 10.57 crore.

Last day! Monika Alcobev IPO closes today; check latest subscription, GMP
Last day! Monika Alcobev IPO closes today; check latest subscription, GMP

Business Standard

time3 days ago

  • Business Standard

Last day! Monika Alcobev IPO closes today; check latest subscription, GMP

Monika Alcobev IPO Day 3 update, subscription status: Three-day subscription window to bid for the initial public offering (IPO) of liquor sector player Monika Alcobev is set to conclude today, July 18. The public offering has so far received favourable demand from investors, getting oversubscribed by 1.51 times by the end of the second day of subscription. The demand among the individual categories was driven by the non-institutional investors (NIIs), who oversubscribed the category reserved for them by 2.95 times. This was followed by the qualified institutional buyers (QIBs), who bid 1.09 times. However, the response from retail investors remains sluggish, as they are yet to fully subscribe to their category. They have booked 87 per cent of their reserved quota. Monika Alcobev IPO key details Monika Alcobev IPO is a book building issue consisting of both fresh as well as offer for sale of equity shares. The SME offering consists of a fresh issue of 4.8 million equity shares worth ₹137.03 crore and an OFS through which shareholders are divesting up to 1 million shares worth nearly ₹28.60 crore. The public issue is available at a price band of ₹271–286 per share and a lot size of 400 shares. Investors can bid for a minimum of 2 lots or 800 shares of Monika Alcobev IPO with an investment amount of ₹2,28,800. Monika Alcobev, in its red herring prospectus (RHP), has said that it will not receive any proceeds from the OFS, as it will be given to shareholders divesting their stakes through the public issue. The company, however, said that it will use the proceeds from the fresh issue of the public offering for repayment and prepayment of certain outstanding borrowings, as well as to fund the working capital requirements. The company will further use the proceeds for general corporate purposes. MUFG Intime India serves as the registrar for the public issue, while Marwadi Chandarana Intermediaries serves as the sole book-running lead manager. Monika Alcobev IPO grey market premium (GMP) today The unlisted shares of Monika Alcobev continue to command a decent premium in the grey market on the final day of subscription. Sources tracking unofficial market activity revealed that the unlisted shares of Monika Alcobev were trading at around ₹296 apiece, indicating a grey market premium (GMP) of ₹10 or 3.50 per cent over the upper end of the issue price of ₹286. Monika Alcobev IPO timeline As the public issue closes for subscription today, the basis for allotment of Monika Alcobev IPO shares is likely to get finalised on Monday, July 21. The successful allottees will receive the company's shares into their demat account tentatively by July 22. Monika Alcobev shares are scheduled to list on the BSE SME, tentatively on July 23. About Monika Alcobev Incorporated in 2015, Monika Alcobev is an imported liquor sector player, offering a diverse portfolio of premium and luxury alcoholic beverages (Source: Technopak Report). Our company specialises in importing, sales, distribution, and marketing of luxury spirits, wines, and liqueurs throughout India and the Indian Subcontinent, including Travel Retail Duty Free Shops. It provides a complete supply chain solution through its robust distribution network. The company holds exclusive selling rights to more than 70 renowned global brands for India and the Indian Subcontinent and is responsible for their strategic brand development and market expansion.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store